| Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy? JA Pinto, CS Vallejos, LE Raez, LA Mas, R Ruiz, JS Torres-Roman, ... ESMO open 3 (3), e000344, 2018 | 138 | 2018 |
| Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer JM Araujo, AC Gomez, A Aguilar, R Salgado, JM Balko, L Bravo, F Doimi, ... Scientific reports 8 (1), 4899, 2018 | 93 | 2018 |
| Treatment of cervical intraepithelial lesions PE Castle, D Murokora, C Perez, M Alvarez, SC Quek, C Campbell International Journal of Gynecology & Obstetrics 138, 20-25, 2017 | 90 | 2017 |
| In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies JA Pinto, C Rolfo, LE Raez, A Prado, JM Araujo, L Bravo, W Fajardo, ... Scientific reports 7 (1), 1526, 2017 | 70 | 2017 |
| Actividad antimicrobiana de plantas J Araujo, R Salas Revista Científica 6, 6-18, 2008 | 54 | 2008 |
| Control of cervical cancer in Peru: Current barriers and challenges for the future A Aguilar, JA Pinto, J Araujo, W Fajardo, L Bravo, L Pinillos, C Vallejos Molecular and Clinical Oncology 5 (2), 241-245, 2016 | 49 | 2016 |
| Characteristics of gastric cancer around the world MJ López, J Carbajal, AL Alfaro, LG Saravia, D Zanabria, JM Araujo, ... Critical Reviews in Oncology/Hematology 181, 103841, 2023 | 44 | 2023 |
| ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer G Rosas, R Ruiz, JM Araujo, JA Pinto, L Mas Critical reviews in oncology/hematology 136, 48-55, 2019 | 42 | 2019 |
| A prognostic signature based on three-genes expression in triple-negative breast tumours with residual disease JA Pinto, J Araujo, NK Cardenas, Z Morante, F Doimi, T Vidaurre, ... NPJ genomic medicine 1 (1), 1-7, 2016 | 41 | 2016 |
| Impact of the delayed initiation of adjuvant chemotherapy in the outcome of triple negative breast cancer Z Morante, R Ruiz, JM Araujo, JA Pinto, G de la Cruz-Ku, ... Clinical Breast Cancer 21 (3), 239-246. e4, 2021 | 29 | 2021 |
| Repeated observation of immune gene sets enrichment in women with non-small cell lung cancer JM Araujo, A Prado, NK Cardenas, M Zaharia, R Dyer, F Doimi, L Bravo, ... Oncotarget 7 (15), 20282, 2016 | 29 | 2016 |
| Mutational analysis of BRCA1 and BRCA2 genes in Peruvian families with hereditary breast and ovarian cancer J Buleje, M Guevara‐Fujita, O Acosta, FDP Huaman, P Danos, A Murillo, ... Molecular genetics & genomic medicine 5 (5), 481-494, 2017 | 25 | 2017 |
| Patterns of mutation enrichment in metastatic triple-negative breast cancer CH Saravia, C Flores, LJ Schwarz, L Bravo, J Zavaleta, J Araujo, ... Clinical Medicine Insights: Oncology 13, 1179554919868482, 2019 | 21 | 2019 |
| Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience G De-la-Cruz-Ku, M Luyo, Z Morante, D Enriquez, MG Möller, ... PloS one 15 (8), e0237811, 2020 | 18 | 2020 |
| Post-recurrence survival in triple negative breast cancer. Z Morante, GA De la Cruz Ku, D Enriquez, A Saavedra, M Lujan, R Luque, ... Journal of Clinical Oncology 36 (15_suppl), e13120-e13120, 2018 | 15 | 2018 |
| Neutrophil-to-lymphocyte ratio predicts early mortality in females with metastatic triple-negative breast cancer G de la Cruz-Ku, D Chambergo-Michilot, JS Torres-Roman, P Rebaza, ... PLoS One 15 (12), e0243447, 2020 | 13 | 2020 |
| Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy? ESMO Open. 2018; 3: e000344 JA Pinto, CS Vallejos, LE Raez, LA Mas, R Ruiz, JS Torres-Roman, ... Journal of Thoracic Disease. All rights reserved. J Thorac Dis 13 (6), 3816-3826, 2021 | 11 | 2021 |
| Precision medicine for locally advanced breast cancer: frontiers and challenges in Latin America JA Pinto, CH Saravia, C Flores, JM Araujo, D Martínez, LJ Schwarz, ... ecancermedicalscience 13, 2019 | 11 | 2019 |
| Sex, immunity, and cancer JA Pinto, JM Araujo, HL Gómez Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1877 (1), 188647, 2022 | 9 | 2022 |
| Lymph node ratio as best prognostic factor in triple‐negative breast cancer patients with residual disease after neoadjuvant chemotherapy GA De la Cruz‐Ku, D Chambergo‐Michilot, B Valcarcel, P Rebaza, ... The breast journal 26 (9), 1659-1666, 2020 | 9 | 2020 |
